Loading data for CBLL — first visit, this takes a few seconds.
CeriBell Inc. (CBLL)
NasdaqGS: CBLL
· Real-Time Price · USD
23.33
+0.08 (0.34%)
At close: Aug 18, 2026, 3:59 PM
CeriBell Inc. (CBLL) Stock Price, Analysis & Data
0.34% (1D)
| Bid | 16.79 |
| Market Cap | 970.2M |
| Revenue (ttm) | 101.96M |
| Net Income (ttm) | -66M |
| Beta | n/a |
| EPS (ttm) | -1.76 |
| PE Ratio (ttm) | n/a |
| Forward PE | -16.45 |
| P/B (ttm) | 7.53 |
| P/S (ttm) | 9.52 |
| Earnings Date | Nov 3, 2026 |
| Ask | 29.72 |
| Volume | 296,039 |
| Avg. Volume (20D) | 373,722 |
| Open | 23.25 |
| Previous Close | 23.25 |
| Day's Range | 23.03 - 23.55 |
| 52-Week Range | 10.85 - 24.33 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CBLL
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered sei...
Industry Medical Devices
Sector Healthcare
IPO Date Oct 11, 2024
Employees 327
Stock Exchange NasdaqGS
Ticker Symbol CBLL
Website https://www.ceribell.com
Financial Performance
In 2025, CeriBell's revenue was 89.06M, an increase of 36.09% compared to the previous year's 65.44M. Earnings were -53.41M, an increase of 32.03%.
Financial StatementsEarnings Surprise
CeriBell has released their quarterly earnings on Aug 10, 2026:
CeriBell Inc. is scheduled to release its earnings on Nov 3, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2